(Q34579405)

English

Arsenic trioxide: a new immunomodulatory agent in the management of multiple myeloma

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Arsenic trioxide: a new immunomodulatory agent in the management of multiple myeloma (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

author name string

Hussein MA

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

239-242

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As(2)O(3)) on myeloma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenicals in hematologic cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma: increasing evidence for a multistep transformation process

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11918450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/MO:18:4:239

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34579405&oldid=2196820430"